Wall Street expects a year-over-year increase in earnings on higher revenues when United Community Banks (UCB) reports ...

Analysts on Wall Street project that United Community Banks (UCB) will announce quarterly earnings of $0.73 per share in its forthcoming report, representing an increase of 15.9% year over year.

Analysts expect the Greenville, South Carolina-based company to report quarterly earnings at 71 cents per share, up from 63 cents per share in the year-ago period. The consensus estimate for United ...

As UCB works to secure U.S. approval for its promising plaque psoriasis prospect bimekizumab, the company has landed an FDA nod in a rare disease where it will challenge Jazz Pharmaceuticals. Fintepla ...

Biogen and UCB’s gamble on advancing into phase 3 on the back of a failed study looks to have paid off, with the partners reporting positive top-line results in systemic lupus erythematosus (SLE) and ...

A UCB drug with a novel approach to plaque psoriasis won a long-awaited FDA approval, positioning it to bring patients a new choice in a crowded market of products for the prevalent skin condition.

UCB is launching a direct-to-consumer (DTC) advertising campaign during the 96th Academy Awards Sunday night in support of its leading treatment for the psoriasis community. The Belgian biopharma is ...

If you have been following UCB (ENXTBR:UCB), the recent moves in its share price have probably caught your eye. After an extended period of subdued trading, investors are starting to wonder if ...